Quest Laboratories (NSE:QUESTLAB) Cash-to-Debt : 0.03 (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Quest Laboratories Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Quest Laboratories's cash to debt ratio for the quarter that ended in Mar. 2024 was 0.03.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Quest Laboratories couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Quest Laboratories's Cash-to-Debt or its related term are showing as below:

NSE:QUESTLAB' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03 Med: 0.08 Max: 0.5
Current: 0.03

During the past 4 years, Quest Laboratories's highest Cash to Debt Ratio was 0.50. The lowest was 0.03. And the median was 0.08.

NSE:QUESTLAB's Cash-to-Debt is ranked worse than
94.4% of 1017 companies
in the Drug Manufacturers industry
Industry Median: 1.02 vs NSE:QUESTLAB: 0.03

Quest Laboratories Cash-to-Debt Historical Data

The historical data trend for Quest Laboratories's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Quest Laboratories Cash-to-Debt Chart

Quest Laboratories Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Cash-to-Debt

0.14

0.50

0.03

Quest Laboratories Quarterly Data
	Mar21	Mar22	Mar23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial			0.50	0.03	0.45	0.01	0.03

Competitive Comparison of Quest Laboratories's Cash-to-Debt

For the Drug Manufacturers - General subindustry, Quest Laboratories's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quest Laboratories's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Quest Laboratories's Cash-to-Debt falls into.

Quest Laboratories Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Quest Laboratories's Cash to Debt Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1.436	/	(38.513	+	12.296)
	=	0.03

Quest Laboratories's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1.436	/	(38.513	+	12.296)
	=	0.03

Quest Laboratories (NSE:QUESTLAB) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Quest Laboratories Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Quest Laboratories's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quest Laboratories Ltd (NSE:QUESTLAB) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot No. 45, Sector III, Pithampur Industrial Area, District Dhar, Pithampur, MP, IND, 454775

Website

https://www.questlabltd.com

Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids.

Quest Laboratories Headlines

No Headlines